摘要
目的 :探讨雷公藤多苷联合糖皮质激素治疗儿童紫癜性肾炎的临床疗效。方法 :选取2009年1月-2011年7月在我院就诊并确诊为紫癜性肾炎(急性肾炎型)的患儿42例,随机分为治疗组和对照组各21例。对照组采用泼尼松、双嘧达莫、维生素C、抗过敏药物、钙剂等常规治疗;治疗组在对照组基础上加用雷公藤多苷治疗。观察分析两组患儿的临床疗效及不良反应。结果 :治疗组患者的治疗总有效率为90.5%,明显高于对照组(71.2%);治疗组患儿血尿、蛋白尿、高血压及水肿等临床症状的消失时间均短于对照组,且复发率明显低于对照组,差异都有统计学意义。结论:小剂量雷公藤多苷联合糖皮质激素治疗儿童紫癜性肾炎临床疗效显著,复发率低,无明显毒副作用,值得临床应用。
Objective： To discuss the clinical efifcacy of tripterygium glycosides combined with glucocorticoid in the treatment of child henoch-schonlein purpura nephritis （HSPN）. Methods：Forty-two cases of child HSPN （acute nephritis type） patients treated in our hospital from January 2009 to July 2011 were divided into a treatment group and a control group with 21 cases each by randomized method. Conventional therapy including prednisone, dipyridamole, vitamin C, anti-allergic drugs and calcium was given in two groups, and in addition, tripterygium glycosides was given in the treatment group. The clinical efifcacy and adverse reaction in both groups were observed and analyzed. Results：The total treatment efifciency in the treatment group was 90.5%, which is higher than that in the control group （71.2%）. The disappear time of all clinical symptoms such as haematuria, proteinuria, hypertension and edema was shorter in the treatment group than in the control group as well as the recurrence rate. All the differences were statistically signiifcant. Conclusion：Small dose of tripterygium glycosides combined with glucocorticoid in the treatment of child henoch-schonlein purpura nephritis has significant clinical efficacy with low recurrence rate and no signiifcant adverse reaction, which is worthy of clinical use.
出处
《上海医药》
CAS
2014年第17期25-27,共3页
Shanghai Medical & Pharmaceutical Journal
基金
2011年江西省卫生厅中医药科研计划课题(2011A009)
关键词
雷公藤多苷
糖皮质激素
紫癜性肾炎
tripterygium glycosides
glucocorticoid
henoch-schonlein purpura nephritis
